Engineered prebiotic microcapsules Co-Encapsulating berberine and curcumin Elicit multi-synergistic therapy for ulcerative colitis
Open Access
- 7 January 2026
- journal article
- Published by Elsevier in Materials Today Bio
- Vol. 37, 102778
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82502548)
- National Key Research and Development Program of China (2022YFC2406600)
- Key Research and Development Projects of Shaanxi Province (2023-YBSF-072)
- Key Research and Development Projects of Shaanxi Province (2024JC-YBMS-664)
This publication has 47 references indexed in Scilit:
- Mucosal barrier dysfunction and relapse in ulcerative colitis: Is there more that meets the eye?Digestive and Liver Disease, 2024
- What Is Ulcerative Colitis?JAMA, 2024
- Ulcerative Colitis in AdultsJAMA, 2023
- Cannabidiol ameliorates inflammatory response partly by AGE‐RAGE pathway in diabetic miceDrug Development Research, 2023
- Nanocarrier‐hydrogel composite delivery systems for precision drug releaseWIREs Nanomedicine and Nanobiotechnology, 2021
- PIK3R3 regulates ZO-1 expression through the NF-kB pathway in inflammatory bowel diseaseInternational Immunopharmacology, 2020
- Role of epithelial cells in the pathogenesis and treatment of inflammatory bowel diseaseJournal of Gastroenterology, 2015
- Mitochondria and NADPH oxidases are the major sources of TNF-α/cycloheximide-induced oxidative stress in murine intestinal epithelial MODE-K cellsCellular Signalling, 2015
- A20 Restricts Ubiquitination of Pro-Interleukin-1β Protein Complexes and Suppresses NLRP3 Inflammasome ActivityImmunity, 2015
- Oxygen radicals in ulcerative colitisFree Radical Biology and Medicine, 1992